- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03875196
The Effect Of Pelvic Floor Muscle Training With Biofeedback And Extracorporeal Magnetic Innervation On The Urinary Symptoms, Sexual Function And Quality Of Life
The Effect Of Pelvic Floor Muscle Training With Bıofeedback And Extracorporeal Magnetic Innervation On The Urinary Symptoms, Sexual Function And Quality Of Life Of Women With Stress Urinary Incontinence
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Introduction and hypothesis: This research was made in order to analyze the impact of the with with Electromyelographic-Biyofeedback added Extracorporeal Magnetic Innervation technique performed on the urinary symptoms, quality of life and sexual function of women with stress urinary incontinence.
Methods: The research type is a pre-test and post-test randomized controlled with experimental nature. The research sample consists of 26 patients in the Biyofeedback group and 25 patients in the with Electromyelographic-Biyofeedback added Extracorporeal Magnetic Innervation group who were examined in the urogynecology policlinics and diagnosed with stress urinary incontinence. between September 2015 and September 2016. At the first meeting, the case report form is filled and the following list is applied for each patience: incontinence life quality scale, female sexual function scale, Q-type test, residue urine volume, one-hour pad test, perineometer, muscle force measurement with Modified Oxford Scale and a three-day bladder diary. Moreover, the Electromyelographic-Biyofeedback was applied to the first group in the clinic for 20 minutes two days a week for eight weeks. The Electromyelographic-Biyofeedback following with 20 minutes Extracorporeal Magnetic Innervation was applied to the second group in the clinic for 20 minutes two days a week for eight weeks. The list applied at the first meeting were repeated after eight weeks.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bornova
-
İzmir, Bornova, Turkey, 35100
- Ege University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- patients diagnosed with stress urinary incontinence
- with pelvic floor power 2 and over,
- sexually active and no restrictions for the magnetic chair treatment.
Exclusion Criteria:
patients with
- prosthesis,
- other implanted metallic devices,
- cardiac pacemaker,
- arrhythmia,
- pelvic malignancies,
- under radiotherapy,
- pelvic floor defect,
- previous surgery for urinary incontinence,
- neurological diseases
- pregnancy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Biyofeedback
the patients underwent 16 sessions of biofeedback-assisted pelvic floor muscle training over 8 weeks for 20 minutes
|
Biyofeedback: The Biyofeedback allows the patient to see the results of her behavior immediately By a perineometer device or electromyelography that is placed in the vagina, the patient sees how she hears the pelvic floor muscles, hears the sound or hears her voice, and detects how much she needs to contract.
|
|
EXPERIMENTAL: Extracorporeal Magnetic Innervation
the patients underwent 16 sessions of biofeedback-assisted pelvic floor muscle training over 8 weeks for 20 minutes and the Extracorporeal Magnetic Innervation application was made for 20 minutes
|
Biyofeedback: The Biyofeedback allows the patient to see the results of her behavior immediately By a perineometer device or electromyelography that is placed in the vagina, the patient sees how she hears the pelvic floor muscles, hears the sound or hears her voice, and detects how much she needs to contract.
Extracorporeal Magnetic Innervation: The patients are seated in a special chair connected to an external power unit and a magnetic field generator inside with their clothes on.
In order to coincide the spreading magnetic field with pelvic floor muscles, the urethral and anal sphincters, the perineum of the patients should be placed in the center of the chair.
In this way, the perineum tissues are stimulated by emitted magnetic field waves.
Thus no electrical current passes through the device to the patient's body and the patient is exposed to only the magnetic current.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pelvic Floor Muscle Strength with Perineometer
Time Frame: In the first encounter and After eight weeks
|
Perineometer: It is a vaginal dynamometer used for objective evaluation of pelvic floor muscle strength during its contractions.
The intravaginal pressure unit is, cmH2O İn.
The pelvic floor muscle strength is evaluated by placing the vaginal probe 3 cm deep inside vagina.
The nominal measurement range is 30-60 cmH2O.
Pressure may decrease to 0-5 cmH2O in patients with weak pelvic floor muscles
|
In the first encounter and After eight weeks
|
|
Pelvic Floor Muscle Strength with Modified Oxford Scale
Time Frame: In the first encounter and After eight weeks
|
Modified Oxford Scale: Grade 0: No contraction. Grade 1: Contraction is minimal. The patient can hold the fingers under 1 second. Grade 2: Contraction is poor. There is no elevation in the fingers. The patient can hold the fingers for 1-3 seconds. Grade 3: The fingers of the therapist are elevated to the posterior vaginal wall with contraction. There is a minimal pressure and the patient can hold the fingers for 4-6 seconds. Grade 4: The fingers of the therapist are elevated to the posterior vaginal wall. There is a sense of intensive pressure on the fingers. The patient can hold the fingers for 7-9 seconds. Grade 5: A strong contraction lasting for 9 seconds and a great resistance against the fingers of the therapist. |
In the first encounter and After eight weeks
|
|
Incontinence Quality of Life
Time Frame: In the first encounter and After eight weeks
|
The quality of life of the patients was measured by the Incontinence Quality of Life Questionnaire IQOL consists of 22 questions and three subscales: behavior limitations (1st, 2nd, 3rd, 4th, 10th, 11th, 13th, 20th items), the psychosocial influence (5th, 6th, 7th, 9th, 15th, 16th, 17th, 21st, 22nd items) and the social isolation (8th, 12th, 14th, 18th, 19th items).
All items in I-QOL are evaluated with a five-category Likert-type scale: 1= very much, 2= quite, 3= moderate, 4= somewhat, 5= not at all.
The calculated total score is converted to a value between 0 to 100 to interpret the results easily.
The increased score obtained from the scale indicates an increase in quality of life.
|
In the first encounter and After eight weeks
|
|
Sexual Function
Time Frame: In the first encounter and After eight weeks
|
Female Sexual Function Index consists of 19 items and 6 subscales developed by Rosen et al. in 2000 to assess female sexual function in the USA.
In this scale, sexual problems or functions in the last four weeks are assessed.
Of the items in the scale, 3-14 and 15-19 are rated on a 6-point Likert scale ranging between 0 and 5, and the rest are rated on a 5-point Likert scale ranging between 1 and 5.
The scoring of the scale items is different.
While the items 1, 2, 15 and 16 are rated as 5-4-3-2-1, the other items are scored as 0-1-2-3-4-5.
The total score for the overall scale is calculated by multiplying the scores obtained from the subscales by the factor loads.
The lowest and highest achievable scores from the scale are 2.0 and 36.0 respectively.
|
In the first encounter and After eight weeks
|
|
The amount of leakage
Time Frame: In the first encounter and After eight weeks
|
Pad Test: In the study, a one-hour pad test standardized by the International Continence Society was applied to the patients and it was evaluated as the following: <2 gr- Dry 2-10 gr- Mild/Moderate Urinary Incontinence 10-50 gr- Severe Urinary Incontinence > 50 gr- Very Severe Urinary Incontinence |
In the first encounter and After eight weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: oya kavlak, proffesor, Ege University
- Study Chair: ahmet özgür yeniel, assosiate prf, Ege University
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-7/5
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Incontinence
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Ludwig-Maximilians - University of MunichUnknownIncontinence, Overactive Bladder, Stress Urinary IncontinenceGermany
-
San Diego Sexual MedicineRecruitingStress Urinary Incontinence | Urge IncontinenceUnited States
-
Copenhagen University Hospital at HerlevZealand University HospitalTerminatedStress Urinary Incontinence | Urge Urinary IncontinenceDenmark
-
Far Eastern Memorial HospitalRecruitingWomen With Stress Urinary IncontinenceTaiwan
-
ScitonCompletedUrinary Incontinence | Stress Urinary Incontinence | Urge IncontinenceUnited States
-
Université de SherbrookeRecruitingUrinary Incontinence | Urinary Stress Incontinence | Post-Prostatectomy Incontinence | Stress Incontinence, MaleCanada
-
University of ZurichCompletedStress Urinary Incontinence | Urge Urinary Incontinence
-
Hadassah Medical OrganizationCompletedUrinary Stress Incontinence (SI)Israel
Clinical Trials on Pelvic Floor Muscle Training With Biofeedback
-
Tanta UniversityRecruitingChildren | Biofeedback | Dysfunctional Voiding | Medical TreatmentEgypt
-
University of the Balearic IslandsFundació d'investigació Sanitària de les Illes Balears; Consejo Superior de...CompletedPelvic Floor DisordersSpain
-
Tanta UniversityRecruitingPremature Ejaculation | Male Sexual Dysfunction | Lifelong Premature EjaculationEgypt
-
Beni-Suef UniversityRecruitingCervical Cancer | Female Sexual Dysfunction (FSD) | Radiation Induced Pelvic Floor Muscle DysfunctionEgypt
-
Texas Woman's UniversityTerminatedStress Urinary IncontinenceUnited States
-
University of PittsburghNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedUrge Urinary IncontinenceUnited States
-
Federal University of Rio Grande do SulUnknownMenopause | Urinary Incontinence, Stress
-
Izmir University of EconomicsHealth Institutes of TurkeyActive, not recruitingChildren | Ultrasound | Pelvic Floor Muscle Training | Dysfunctional Voiding | DNSTurkey (Türkiye)
-
Hasan Kalyoncu UniversityNot yet recruiting
-
Mingfu WuPeking Union Medical College Hospital; Peking University Third Hospital; Southwest... and other collaboratorsRecruitingPelvic Organ Prolapse | Pelvic Floor DisordersChina